What it's for (Indications)
- This combination supplement, comprising calcium, vitamin D3 (cholecalciferol), and vitamin K2 (menaquinone), is primarily indicated for the prevention and treatment of bone mineral density loss, including osteopenia and osteoporosis, particularly in individuals with documented dietary deficiencies of calcium and/or vitamin D.
- It is also used as an adjunctive therapy in postmenopausal osteoporosis, corticosteroid-induced osteoporosis, and senile osteoporosis to support optimal bone health and reduce fracture risk.
- Furthermore, it addresses conditions associated with inadequate calcium or vitamin D intake or absorption, such as malabsorption syndromes, chronic kidney disease (under medical supervision), and long-term immobility.
- The synergistic action of its components aims to enhance calcium absorption, utilization, and deposition into the bone matrix, while simultaneously deterring undesirable calcium accumulation in soft tissues and vasculature.
- This comprehensive approach targets the multifaceted aspects of maintaining skeletal integrity and overall calcium homeostasis within the body.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The precise dosage of calcium, vitamin D3, and vitamin K2 must be individualized based on the patient's age, specific medical condition, baseline nutritional status, and existing dietary intake, always under the guidance of a healthcare professional. For adult supplementation, common elemental calcium dosages range from 500 mg to 1200 mg daily, typically administered in divided doses to optimize absorption. Vitamin D3 (cholecalciferol) is often provided in concentrations ranging from 400 IU to 2000 IU (10 mcg to 50 mcg) daily, though higher doses may be prescribed for individuals with significant deficiency. Vitamin K2 (menaquinone), often in the MK-7 form due to its longer half-life, is commonly included in amounts from 45 mcg to 180 mcg daily. It is crucial to adhere strictly to the physician's prescribed regimen or the product's recommended daily allowance, and not to exceed the tolerable upper intake levels for any component, especially calcium and vitamin D, without medical supervision due to the risk of hypercalcemia. Administration with food is generally recommended to enhance absorption and minimize gastrointestinal upset. |
Safety & Warnings
Common Side Effects
- While generally well-tolerated when taken as directed, calcium, vitamin D3, and vitamin K2 supplementation can sometimes lead to adverse effects.
- Common gastrointestinal disturbances include constipation, abdominal bloating, gas, and mild nausea.
- Less frequently, individuals may experience stomach upset or diarrhea.
- In cases of excessive intake, particularly of calcium and vitamin D, or in susceptible individuals, more serious side effects related to hypercalcemia can occur.
- These symptoms include severe constipation, persistent nausea or vomiting, loss of appetite, increased thirst and urination, muscle weakness, fatigue, confusion, and in severe instances, cardiac arrhythmias and kidney dysfunction or stone formation.
- Allergic reactions, though rare, can manifest as rash, itching, swelling, severe dizziness, or trouble breathing.
- Patients with pre-existing conditions such as kidney stones, hyperparathyroidism, or sarcoidosis should use this combination with extreme caution and under strict medical supervision.
- Any persistent or severe side effects should prompt immediate consultation with a healthcare provider.
Serious Warnings
- Black Box Warning: None
- This combination supplement is contraindicated in patients with hypercalcemia (elevated blood calcium levels), hypercalciuria (elevated urinary calcium levels), hypervitaminosis D, or known hypersensitivity to any of its components.
- Caution is advised for individuals with a history of kidney stones, renal impairment, or conditions that predispose to hypercalcemia, such as sarcoidosis, certain cancers, or hyperparathyroidism, as these may exacerbate their condition.
- Close monitoring of serum calcium and creatinine levels is recommended in such patients.
- Potential drug interactions are significant: calcium can interfere with the absorption of certain medications, including tetracycline and quinolone antibiotics, bisphosphonates, and thyroid hormones; these should be administered at least 2-4 hours apart.
- Vitamin K2 can interfere with the action of anticoagulant medications, particularly warfarin, potentially reducing its effectiveness and increasing the risk of blood clots; patients on warfarin must consult their physician before starting or stopping this supplement, and INR levels should be closely monitored.
- Thiazide diuretics can increase the risk of hypercalcemia when taken concurrently with calcium and vitamin D.
- Digoxin toxicity may be increased by hypercalcemia.
- Pregnant and lactating women should only use this product under medical guidance.
How it Works (Mechanism of Action)
This tripartite formulation synergistically addresses bone health through distinct yet complementary mechanisms. **Calcium** serves as the primary structural component of bones and teeth, forming hydroxyapatite crystals that provide rigidity and strength. Beyond its structural role, calcium is vital for numerous physiological processes, including nerve impulse transmission, muscle contraction, blood coagulation, and cell signaling. Its availability is crucial for maintaining bone mineral density and preventing skeletal demineralization. **Vitamin D3 (cholecalciferol)**, a fat-soluble secosteroid, plays a pivotal role in calcium and phosphate homeostasis. It acts by stimulating the absorption of dietary calcium and phosphate from the gastrointestinal tract, promoting their reabsorption in the kidneys, and facilitating their incorporation into the bone matrix. Vitamin D3 also regulates parathyroid hormone (PTH) secretion, preventing excessive bone resorption. It ensures that adequate calcium is available for bone mineralization. **Vitamin K2 (menaquinone)**, another fat-soluble vitamin, works by activating specific vitamin K-dependent proteins crucial for bone metabolism and arterial health. It carboxylates osteocalcin, a protein produced by osteoblasts, enabling it to bind calcium effectively and direct it into the bone matrix for mineralization. Concurrently, Vitamin K2 activates matrix Gla protein (MGP), which is a potent inhibitor of soft tissue calcification, particularly in blood vessels and cartilage. This dual action ensures that calcium is efficiently utilized for building and maintaining strong bones, while preventing its inappropriate deposition in arteries, thereby reducing the risk of vascular calcification and cardiovascular complications. The combined effect promotes optimal calcium utilization and bone integrity.
Commercial Brands (Alternatives)
No other brands found for this formula.